ODDITY Tech Ltd.(ODD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ODD ODDITY Tech Ltd.

Trading 03-12 15:41:24 EDT

13.51

+0.97

+7.69%

High14.59	Low13.36	Vol2.73M
Open13.61	D1 Closing12.55	Amplitude9.84%
Mkt Cap776.00M	Tradable Cap522.79M	Total Shares57.44M
T/O37.72M	T/O Rate7.05%	Tradable Shares38.70M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ODD","market":"US","secType":"STK","nameCN":"ODDITY Tech Ltd.","latestPrice":13.51,"timestamp":1773344483204,"preClose":12.545,"halted":0,"volume":2729189,"delay":0,"changeRate":0.07692307692307691,"floatShares":38696732,"shares":57438900,"eps":1.791771,"marketStatus":"Trading","change":0.965,"latestTime":"03-12 15:41:24 EDT","open":13.61,"high":14.59,"low":13.355,"amount":37717331.937842004,"amplitude":0.098446,"askPrice":13.51,"askSize":1,"bidPrice":13.5,"bidSize":4,"shortable":3,"etf":0,"ttmEps":1.791771,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1773345600000},"marketStatusCode":2,"adr":0,"listingDate":1689739200000,"exchange":"NASDAQ","adjPreClose":12.545,"preHourTrading":{"tag":"盘前","latestPrice":13.61,"preClose":12.545,"latestTime":"09:29 EDT","volume":85805,"amount":1114452.32939,"timestamp":1773322199999,"change":1.065,"changeRate":0.084894,"amplitude":0.08943},"postHourTrading":{"tag":"盘后","latestPrice":12.5013,"preClose":12.545,"latestTime":"19:57 EDT","volume":5529,"amount":69894.2754,"timestamp":1773273478402,"change":-0.0437,"changeRate":-0.003483,"amplitude":0.023013},"volumeRatio":0.832609,"impliedVol":1.0578,"impliedVolPercentile":0.988},"requestUrl":"/m/hq/s/ODD","defaultTab":"news","newsList":[{"id":"2618131200","title":"Press Release: ODDITY Tech Announces $200m Share Buyback Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2618131200","media":"Dow Jones","labels":["shareholding"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/2618131200?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:00","pubTimestamp":1773316800,"startTime":"0","endTime":"0","summary":"NEW YORK, March 12, 2026  -- ODDITY Tech Ltd.  , today announced that its Board of Directors has approved a share buyback program  authorizing the repurchase of a maximum of $200 million of the Company's Class A ordinary shares, subject to market conditions, legal and regulatory constraints, the terms of the Buyback Plan, and other strategic priorities. The Buyback Plan replaces and supersedes the Company's previously announced $150 million share buyback plan. The Buyback Plan will expire on March 31, 2029 or once the allocated funds have been fully deployed, subject to any future modifications by the Board.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: ODDITY Tech Announces $200m Share Buyback Plan","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","ODD","BK4183"],"gpt_icon":0},{"id":"2618131077","title":"Oddity Tech board approves USD 200 million share buyback plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2618131077","media":"Reuters","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618131077?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:08","pubTimestamp":1773317325,"startTime":"0","endTime":"0","summary":"Oddity said its board approved a share buyback program authorizing repurchases of up to USD 200 million of its Class A ordinary shares. The company said the new program replaces and supersedes its prior USD 150 million buyback plan and expires on March 31, 2029. Oddity said it had repurchased about USD 97 million under the prior authorization, including about USD 50 million year-to-date. The company said repurchases may be conducted in the open market, including under Rule 10b5-1 trading plans, or in privately negotiated transactions. Oddity said the program does not obligate it to repurchase any specific number of shares and may be suspended, modified, or discontinued at any time.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oddity ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDLbBsJbV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","IE0009354923.USD","ODD"],"gpt_icon":0},{"id":"2618131439","title":"Oddity Tech Announces $200M Share Buyback Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2618131439","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618131439?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:00","pubTimestamp":1773316807,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nTUA8CL1QQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ODD","BK4183","IE0009354923.USD"],"gpt_icon":0},{"id":"2618795131","title":"Cadrenal Therapeutics Highlights Research Supporting 12-LOX Inhibition in Reducing Inflammation in Obesity and Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2618795131","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618795131?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:00","pubTimestamp":1773316800,"startTime":"0","endTime":"0","summary":"PONTE VEDRA, Fla., March  12, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing innovative treatments for life-threatening immune and thrombot","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/12/3254535/0/en/Cadrenal-Therapeutics-Highlights-Research-Supporting-12-LOX-Inhibition-in-Reducing-Inflammation-in-Obesity-and-Type-2-Diabetes.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIT","ODD","LENZ","BK4539","BK4173","IE0009354923.USD","BK4139","BK4007","BK4183"],"gpt_icon":0},{"id":"2618032692","title":"ODDITY Tech Earnings Call: Growth Meets Digital Shock","url":"https://stock-news.laohu8.com/highlight/detail?id=2618032692","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618032692?lang=en_us&edition=fundamental","pubTime":"2026-03-09 08:10","pubTimestamp":1773015013,"startTime":"0","endTime":"0","summary":"ODDITY Tech Ltd. Class A (($ODD)) has held its Q4 earnings call. Read on for the main highlights of the call. ODDITY Tech’s latest earnings call pa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oddity-tech-earnings-call-growth-meets-digital-shock?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oddity-tech-earnings-call-growth-meets-digital-shock?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ODD"],"gpt_icon":0},{"id":"2617668076","title":"Press Release: PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2617668076","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617668076?lang=en_us&edition=fundamental","pubTime":"2026-03-06 21:00","pubTimestamp":1772802000,"startTime":"0","endTime":"0","summary":"-- Enrollment remains on track in Phase 2 pivotal portion of PYNNACLE trial. ovarian cancer patients with a TP53 Y220C mutation. -- Rezatapopt granted Orphan Drug Designation by the U.S. Food and Drug. Administration for the treatment of TP53 Y220C positive ovarian cancer. -- New England Journal of Medicine published first-in-human rezatapopt data. showing selective reactivation of mutant p53 in advanced solid tumors. -- Cash, cash equivalents, and marketable securities of $112.9 million as of. December 31, 2025 providing expected cash runway to end of second quarter. PRINCETON, N.J., March 06, 2026  -- PMV Pharmaceuticals, Inc. , a precision oncology company pioneering the discovery and development of small molecule therapies targeting p53, today reported financial results for the full year ended December 31, 2025, and provided a corporate update.clinical trial. The multicenter, single-arm, registrational Phase 2 study. is assessing rezatapopt as monotherapy at a dose of 2000 mg once-","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT","IE0009354923.USD","PMVP","BK4183","LU1878469433.USD","ORR","BK4139","ODD","BK4599"],"gpt_icon":0},{"id":"2616132550","title":"Immix Biopharma to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2616132550","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616132550?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:45","pubTimestamp":1772545500,"startTime":"0","endTime":"0","summary":"LOS ANGELES, CA, March  03, 2026  (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced th","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/03/3248394/0/en/Immix-Biopharma-to-Participate-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODD","BK4183","IE0009354923.USD"],"gpt_icon":0},{"id":"2616339369","title":"Bragar Eagel & Squire Investigates Oddity Tech Over Possible Securities Law Violations","url":"https://stock-news.laohu8.com/highlight/detail?id=2616339369","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616339369?lang=en_us&edition=fundamental","pubTime":"2026-03-03 08:57","pubTimestamp":1772499472,"startTime":"0","endTime":"0","summary":"Bragar Eagel and Squire is investigating potential claims on behalf of Oddity Tech Ltd. stockholders, examining whether the company violated federal securities laws or engaged in unlawful business practices. The probe follows Oddity’s disclosure of an advertising-account dislocation tied to algorithm changes that it said increased costs and hurt auction quality, after which the stock fell.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL5fMDsG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","LU0314104364.USD","LU2210150020.SGD","BK4588","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","ODD","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU2095319765.USD","SG9999014005.SGD","IE0009354923.USD","SG9999014021.USD","BK4585","SG9999014013.SGD","NDAQ","LU2210149790.SGD","SG9999014039.USD","BK4112"],"gpt_icon":0},{"id":"2616363170","title":"Unilever PLC Stock Moved Down by 3.16% on Mar 2: Facts Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2616363170","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616363170?lang=en_us&edition=fundamental","pubTime":"2026-03-03 03:15","pubTimestamp":1772478926,"startTime":"0","endTime":"0","summary":"• Unilever shares fell due to 2025 earnings and 2026 targets.\n• Analysts doubt Unilever's 2026 growth and margin targets.\n• Some financial institutions downgraded Unilever's stock rating.","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/stocks/261636557-market-movers-ul-20260302","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124676726.USD","BK4192","BK4585","ULVR.UK","UL","BK4539","BK4583","AXIL","BK4592","EJH","BK4183","LU0689626769.HKD","ODD","BK4588","UN","IE0009354923.USD"],"gpt_icon":0},{"id":"2616303703","title":"Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2616303703","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616303703?lang=en_us&edition=fundamental","pubTime":"2026-03-02 21:00","pubTimestamp":1772456400,"startTime":"0","endTime":"0","summary":"Encouraging data for CAD-1005 in Phase 2 HIT Study EOP2 scheduled for Q1 for top-priority indication Additional acute and chronic opportunities for 12-LOX inhibition beyond HIT PONTE VEDRA, Fla., Marc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/02/3247318/0/en/Cadrenal-Therapeutics-Highlights-Recent-12-LOX-Inhibitor-Platform-Expansion.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","BK4183","BK4539","ODD","BK4173","IE0009354923.USD","HIT","LENZ"],"gpt_icon":0},{"id":"2614307822","title":"Oddity Tech Shares Fall After Multiple Analyst Downgrades","url":"https://stock-news.laohu8.com/highlight/detail?id=2614307822","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614307822?lang=en_us&edition=fundamental","pubTime":"2026-02-27 03:45","pubTimestamp":1772135131,"startTime":"0","endTime":"0","summary":"Oddity Tech  shares fell 6.8% in recent Thursday trading after multiple analysts downgraded their ratings and cut their price targets on the beauty and wellness products company's stock.Evercore ISI downgraded the stock to in line from outperform and cut its price target to $23 from $80, while Barclays lowered its rating to underweight from equal weight and cut its price target to $13 from $40.Needham downgraded the stock to hold from buy, while JPMorgan cut its price target to $16 from $59 and downgraded its rating to neutral from overweight.Oddity Tech's intraday volume exceeded 8.8 million shares, versus the daily average of over 936,000.Price: 13.74, Change: -1.00, Percent Change: -6.78","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4183","IE0009354923.USD","ODD"],"gpt_icon":0},{"id":"2614023306","title":"ODDITY Tech Is Maintained at Overweight by Keybanc","url":"https://stock-news.laohu8.com/highlight/detail?id=2614023306","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614023306?lang=en_us&edition=fundamental","pubTime":"2026-02-26 22:44","pubTimestamp":1772117040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ODD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 26, 2026 09:44 ET (14:44 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODD"],"gpt_icon":0},{"id":"2614967042","title":"Oddity Tech Ltd :  Truist Securities Cuts to Hold From Buy; Cuts Target Price to $18 From $80","url":"https://stock-news.laohu8.com/highlight/detail?id=2614967042","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614967042?lang=en_us&edition=fundamental","pubTime":"2026-02-26 21:26","pubTimestamp":1772112409,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nFWN3ZM1S8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009354923.USD","ODD","BK4183"],"gpt_icon":0},{"id":"2614041593","title":"Needham Downgrades ODDITY Tech to Hold From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2614041593","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614041593?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:44","pubTimestamp":1772109896,"startTime":"0","endTime":"0","summary":"Needham Downgrades ODDITY Tech to Hold From Buy","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ODD"],"gpt_icon":0},{"id":"2614519041","title":"Evercore ISI Downgrades ODDITY Tech to In Line From Outperform, Adjusts PT to $23 From $80","url":"https://stock-news.laohu8.com/highlight/detail?id=2614519041","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614519041?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:44","pubTimestamp":1772109875,"startTime":"0","endTime":"0","summary":"Evercore ISI Downgrades ODDITY Tech to In Line From Outperform, Adjusts PT to $23 From $80","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ODD"],"gpt_icon":0},{"id":"2614041828","title":"Barclays Downgrades ODDITY Tech to Underweight From Equal Weight, Adjusts PT to $13 From $40","url":"https://stock-news.laohu8.com/highlight/detail?id=2614041828","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614041828?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:42","pubTimestamp":1772109741,"startTime":"0","endTime":"0","summary":"Barclays Downgrades ODDITY Tech to Underweight From Equal Weight, Adjusts PT to $13 From $40","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ODD"],"gpt_icon":0},{"id":"2614041847","title":"JPMorgan Downgrades ODDITY Tech to Neutral From Overweight, Adjusts PT to $16 From $59","url":"https://stock-news.laohu8.com/highlight/detail?id=2614041847","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614041847?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:42","pubTimestamp":1772109738,"startTime":"0","endTime":"0","summary":"JPMorgan Downgrades ODDITY Tech to Neutral From Overweight, Adjusts PT to $16 From $59","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ODD"],"gpt_icon":0},{"id":"2614046679","title":"Morgan Stanley Cuts Price Target on ODDITY Tech to $16 From $49, Keeps Equalweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2614046679","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614046679?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:12","pubTimestamp":1772107962,"startTime":"0","endTime":"0","summary":"ODDITY Tech (ODD) has an average rating of hold and mean price target of $18.22, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ODD"],"gpt_icon":0},{"id":"2614045439","title":"Oddity price target lowered to $20 from $50 at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2614045439","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614045439?lang=en_us&edition=fundamental","pubTime":"2026-02-26 19:53","pubTimestamp":1772106837,"startTime":"0","endTime":"0","summary":"Goldman Sachs lowered the firm’s price target on Oddity (ODD) to $20 from $50 and keeps a Neutral rating on the shares. Oddity delivered another st...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oddity-price-target-lowered-to-20-from-50-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oddity-price-target-lowered-to-20-from-50-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2265009873.SGD","LU2237443622.USD","LU2471134796.USD","IE00BFXG1179.USD","IE00BSNM7G36.USD","LU0345770308.USD","IE0002270589.USD","BK4533","LU2750360997.AUD","LU1868836914.USD","LU0251131958.USD","GSX","LU1804176565.USD","LU0106831901.USD","LU1894683264.USD","LU2237443895.HKD","LU2471134879.HKD","LU2237443549.SGD","LU1868837300.USD","LU1668664300.SGD","BK4588","BK4585","LU1868837136.USD","BK4516","LU0742534661.SGD","LU2237443382.USD","LU2237443978.SGD","LU0345770993.USD","LU2237438978.USD","LU2237443465.HKD","BK4504","LU0251142724.SGD","LU0061475181.USD","BK4127","ODD","BK4550","LU1894683348.USD","LU1791807156.HKD","IE0004091025.USD","IE0034235188.USD","LU1868836591.USD","LU2471134952.CNY","LU2471134523.USD","BK4183","LU2750360641.GBP","IE0009354923.USD","LU0096364046.USD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","LU0048573561.USD"],"gpt_icon":0},{"id":"2614010051","title":"Oddity Tech Ltd. : Barclays Cuts to Underweight From Equal-Weight","url":"https://stock-news.laohu8.com/highlight/detail?id=2614010051","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614010051?lang=en_us&edition=fundamental","pubTime":"2026-02-26 19:18","pubTimestamp":1772104706,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nAZN4SIGE9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","IE0009354923.USD","ODD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://oddity.com","stockEarnings":[{"period":"1week","weight":-0.035},{"period":"1month","weight":-0.5776},{"period":"3month","weight":-0.7177},{"period":"6month","weight":-0.8003},{"period":"1year","weight":-0.7168},{"period":"ytd","weight":-0.6878}],"compareEarnings":[{"period":"1week","weight":-0.0128},{"period":"1month","weight":-0.0254},{"period":"3month","weight":-0.0186},{"period":"6month","weight":0.0288},{"period":"1year","weight":0.2166},{"period":"ytd","weight":-0.0082}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Oddity Tech Ltd. operates as a consumer tech company that builds and scales digital-first brands to disrupt beauty and wellness industries. The company serves consumers worldwide through its AI-driven online platform, deploying data science to identify consumer needs, and developing solutions in the form of beauty and wellness products. It owns IL MAKIAGE and SpoiledChild brands. The company was incorporated in 2013 and is headquartered in Tel Aviv, Israel with additional office in New York, New York.","exchange":"NASDAQ","name":"ODDITY Tech Ltd.","nameEN":"ODDITY Tech Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ODDITY Tech Ltd.(ODD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ODDITY Tech Ltd.(ODD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ODDITY Tech Ltd.,ODD,ODDITY Tech Ltd.股票,ODDITY Tech Ltd.股票老虎,ODDITY Tech Ltd.股票老虎国际,ODDITY Tech Ltd.行情,ODDITY Tech Ltd.股票行情,ODDITY Tech Ltd.股价,ODDITY Tech Ltd.股市,ODDITY Tech Ltd.股票价格,ODDITY Tech Ltd.股票交易,ODDITY Tech Ltd.股票购买,ODDITY Tech Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ODDITY Tech Ltd.(ODD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ODDITY Tech Ltd.(ODD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}